Trials / Completed
CompletedNCT05149001
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 667 (actual)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is perform to study the effect of psychological and psychosocial factors associated with resilience to the self-stigmatization of people living with HIV
Detailed description
Epidemiological and sociological survey carried out with patients and their caregivers in the CHUs and CHGs of France via the COREVIH from 01/17/2022 to 02/17/2022. Primary endpoint: Self-stigmatization as experienced by PLWHA will be explored through a patient questionnaire Secondary endpoints:The main explanatory variables will be studied by means of a custom questionnaire intended for the patient and covering psychological flexibility, social provisions, avoidance and fusion mechanisms, quality of life, anxiety and depression. The socio-demographic explanatory variables will be collected by questionnaire, covering the following areas: sex, age, geographical origin, insecurity, drug use, sexuality, family context, employment, leisure, care environment. A questionnaire intended for caregivers will study the self-stigmatization perception of the people they care for and the means implemented to fight against self-stigmatization. Anonymous data will be reported in Redcap. The population will be described by numbers and percentages for categorical variables and by the mean ± standard deviation or the median \[interquartile range\] for the quantitative variables, with regard to their statistical distribution. Normality will be studied by the Shapiro-Wilk test and / or by histogram. As far as possible, graphical representations will be associated with the analyzes.
Conditions
Timeline
- Start date
- 2022-01-17
- Primary completion
- 2022-04-14
- Completion
- 2022-04-14
- First posted
- 2021-12-08
- Last updated
- 2023-05-01
Locations
43 sites across 3 countries: France, Guadeloupe, Reunion
Source: ClinicalTrials.gov record NCT05149001. Inclusion in this directory is not an endorsement.